In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

Published Date: 15 Dec 2023

Comparing marstacimab to prophylactic, on-demand treatments, the annualized bleeding rate was lower.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

2.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

3.

Aster Whitefield Hospital, with 506 beds, opened.

4.

New First-Line Option for Advanced ALK-Positive Lung Cancer

5.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot